Actively Recruiting
Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy
Led by Cairo University · Updated on 2025-04-08
90
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia for chronic pain management after mastectomy.
CONDITIONS
Official Title
Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 75 years
- American Society of Anesthesiologists (ASA) physical status II
- Scheduled for mastectomy with axillary dissection due to breast cancer, including modified radical mastectomy with or without latissimus dorsi flap or conservative breast surgery
You will not qualify if you...
- Patient refusal
- Known allergy to any of the study drugs
- Hepatic or renal insufficiency
- Regular use of beta blockers
- Use of alpha-2 adrenergic agonists and sedatives
- Use of psychoactive medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 12613
Actively Recruiting
Research Team
M
Mohamed E Abdel Fattah, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here